X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-16 | SGEN | Liu Jean I | GC | S - Sale+OE | $199.90 | -5,000 | 85,113 | -6% | -$999,500 | |||||
| D | 2023-03-15 | SGEN | Welch Daniel G | Dir | S - Sale+OE | $200.05 | -3,603 | 29,959 | -11% | -$720,780 | |||||
| D | 2023-03-15 | SGEN | Dansey Roger D | Pres, R, D, CMO | S - Sale+OE | $199.81 | -10,000 | 96,853 | -9% | -$1,998,115 | |||||
| DM | 2023-03-13 | SGEN | Welch Daniel G | Dir | S - Sale+OE | $200.35 | -27,397 | 31,525 | -46% | -$5,488,901 | |||||
| D | 2023-03-09 | SGEN | Simpson Todd E | CFO | S - Sale+OE | $176.61 | -42,793 | 117,185 | -27% | -$7,557,550 | |||||
| D | 2023-03-02 | SGEN | Himes Vaughn B | Chief Technical Officer | S - Sale+OE | $177.21 | -16,215 | 186,728 | -8% | -$2,873,477 | |||||
2023-02-27 | SGEN | Simpson Todd E | CFO | S - Sale | $182.53 | -20,000 | 117,185 | -15% | -$3,650,600 | ||||||
| D | 2023-02-16 | SGEN | Simpson Todd E | CFO | S - Sale+OE | $160.00 | -39,946 | 137,185 | -23% | -$6,391,400 | |||||
| D | 2023-02-16 | SGEN | Liu Jean I | GC | S - Sale+OE | $155.00 | -5,000 | 85,113 | -6% | -$775,000 | |||||
| D | 2023-02-15 | SGEN | Dansey Roger D | Pres, R, D, CMO | S - Sale+OE | $140.64 | -10,000 | 96,853 | -9% | -$1,406,395 | |||||
2023-02-02 | SGEN | Dansey Roger D | Pres, R, D, CMO | S - Sale | $138.52 | -783 | 96,853 | -1% | -$108,461 | ||||||
| D | 2023-01-24 | SGEN | Dansey Roger D | Pres, R, D, CMO | S - Sale+OE | $135.00 | -10,000 | 97,539 | -9% | -$1,350,000 | |||||
| D | 2023-01-24 | SGEN | Liu Jean I | GC | S - Sale+OE | $135.03 | -5,000 | 85,113 | -6% | -$675,134 | |||||
2023-01-17 | SGEN | Liu Jean I | GC | S - Sale | $130.71 | -578 | 85,113 | -1% | -$75,548 | ||||||
| DM | 2023-01-04 | SGEN | Dansey Roger D | Pres R, D, CMO | S - Sale+OE | $135.00 | -10,000 | 97,539 | -9% | -$1,350,000 | |||||
| DM | 2023-01-04 | SGEN | Liu Jean I | GC | S - Sale+OE | $135.00 | -5,000 | 85,691 | -6% | -$675,000 | |||||
2022-12-20 | SGEN | Romp Charles R | EVP, Commercial U.S. | S - Sale | $127.63 | -1,129 | 58,475 | -2% | -$144,094 | ||||||
| D | 2022-12-14 | SGEN | Dansey Roger D | Pres, Research, Develo | S - Sale+OE | $135.00 | -10,000 | 97,539 | -9% | -$1,350,000 | |||||
| D | 2022-11-17 | SGEN | Liu Jean I | GC | S - Sale+OE | $131.05 | -8,333 | 85,691 | -9% | -$1,092,056 | |||||
2022-11-11 | SGEN | Gryska David W | Dir | S - Sale | $129.10 | -7,500 | 40,253 | -16% | -$968,220 | ||||||
| D | 2022-10-17 | SGEN | Dansey Roger D | Interim CEO, CMO | S - Sale+OE | $135.00 | -10,000 | 97,539 | -9% | -$1,350,000 | |||||
2022-08-31 | SGEN | Simpson Todd E | CFO | S - Sale | $154.42 | -4,186 | 137,185 | -3% | -$646,379 | ||||||
2022-08-31 | SGEN | Himes Vaughn B | Chief Technical Officer | S - Sale | $154.42 | -3,584 | 186,654 | -2% | -$553,422 | ||||||
2022-08-31 | SGEN | Romp Charles R | EVP, Commercial | S - Sale | $154.42 | -1,133 | 59,604 | -2% | -$174,952 | ||||||
2022-08-31 | SGEN | Dansey Roger D | Interim CEO, CMO | S - Sale | $154.42 | -5,019 | 97,539 | -5% | -$775,006 | ||||||
2022-08-31 | SGEN | Liu Jean I | GC | S - Sale | $154.42 | -3,648 | 84,390 | -4% | -$563,304 | ||||||
2022-08-16 | SGEN | Simpson Todd E | CFO | S - Sale | $170.22 | -1,967 | 141,371 | -1% | -$334,813 | ||||||
2022-08-16 | SGEN | Romp Charles R | EVP, Commercial | S - Sale | $170.22 | -1,765 | 60,737 | -3% | -$300,430 | ||||||
2022-08-16 | SGEN | Liu Jean I | GC | S - Sale | $170.22 | -1,639 | 88,038 | -2% | -$278,983 | ||||||
2022-08-16 | SGEN | Himes Vaughn B | Chief Technical Officer | S - Sale | $170.22 | -1,527 | 190,238 | -1% | -$259,918 | ||||||
2022-08-16 | SGEN | Dansey Roger D | Interim CEO, CMO | S - Sale | $170.22 | -4,254 | 102,558 | -4% | -$724,095 | ||||||
2022-07-05 | SGEN | Romp Charles R | EVP, Commercial | S - Sale | $179.46 | -712 | 48,771 | -1% | -$127,776 | ||||||
| D | 2022-06-28 | SGEN | Dansey Roger D | Chief Medical Officer | S - Sale+OE | $180.00 | -34,635 | 62,084 | -36% | -$6,234,300 | |||||
| D | 2022-06-17 | SGEN | Himes Vaughn B | Chief Technical Officer | S - Sale+OE | $160.00 | -1,134 | 179,669 | -1% | -$181,440 | |||||
| D | 2022-05-24 | SGEN | Himes Vaughn B | Chief Technical Officer | S - Sale+OE | $136.79 | -10,866 | 179,669 | -6% | -$1,486,377 | |||||
2022-05-16 | SGEN | Romp Charles R | EVP, Commercial | S - Sale | $134.21 | -333 | 49,483 | -1% | -$44,691 | ||||||
| D | 2022-05-12 | SGEN | Siegall Clay B | Pres, CEO | S - Sale+OE | $125.69 | -17,043 | 666,060 | -2% | -$2,142,117 | |||||
2022-04-20 | SGEN | Siegall Clay B | Pres, CEO | S - Sale | $144.32 | -1,885 | 666,060 | 0% | -$272,041 | ||||||
2022-04-20 | SGEN | Simpson Todd E | CFO | S - Sale | $144.32 | -567 | 127,891 | 0% | -$81,829 | ||||||
2022-04-20 | SGEN | Liu Jean I | GC | S - Sale | $144.32 | -401 | 75,946 | -1% | -$57,872 | ||||||
2022-04-20 | SGEN | Romp Charles R | EVP, Commercial | S - Sale | $144.32 | -319 | 49,816 | -1% | -$46,038 | ||||||
2022-04-20 | SGEN | Himes Vaughn B | Chief Technical Officer | S - Sale | $144.32 | -574 | 179,669 | 0% | -$82,839 | ||||||
| M | 2022-04-20 | SGEN | Dansey Roger D | Chief Medical Officer | S - Sale | $144.24 | -1,439 | 76,975 | -2% | -$207,565 | |||||
| D | 2022-04-19 | SGEN | Gryska David W | Dir | S - Sale+OE | $143.95 | -4,000 | 46,250 | -8% | -$575,783 | |||||
| D | 2022-04-07 | SGEN | Siegall Clay B | Pres, CEO | S - Sale+OE | $154.23 | -17,043 | 667,945 | -2% | -$2,628,610 | |||||
| D | 2022-03-07 | SGEN | Siegall Clay B | Pres, CEO | S - Sale+OE | $134.35 | -17,043 | 667,945 | -2% | -$2,289,655 | |||||
| D | 2022-03-03 | SGEN | Himes Vaughn B | Chief Technical Officer | S - Sale+OE | $127.05 | -12,000 | 180,105 | -6% | -$1,524,558 | |||||
| D | 2022-02-07 | SGEN | Siegall Clay B | Pres, CEO | S - Sale+OE | $139.97 | -17,043 | 667,945 | -2% | -$2,385,566 | |||||
| D | 2022-02-07 | SGEN | Gryska David W | Dir | S - Sale+OE | $138.77 | -4,500 | 46,250 | -9% | -$624,441 | |||||
| M | 2022-02-02 | SGEN | Dansey Roger D | Chief Medical Officer | S - Sale | $136.88 | -1,442 | 78,244 | -2% | -$197,378 | |||||
| D | 2022-01-28 | SGEN | Gryska David W | Dir | S - Sale+OE | $122.56 | -4,500 | 46,250 | -9% | -$551,539 | |||||
| D | 2022-01-14 | SGEN | Gryska David W | Dir | S - Sale+OE | $135.24 | -4,500 | 46,250 | -9% | -$608,581 | |||||
| D | 2022-01-07 | SGEN | Siegall Clay B | Pres, CEO | S - Sale+OE | $144.73 | -17,044 | 667,945 | -2% | -$2,466,743 | |||||
2022-01-03 | SGEN | Dansey Roger D | Chief Medical Officer | S - Sale | $152.58 | -8,675 | 79,686 | -10% | -$1,323,648 | ||||||
2021-12-20 | SGEN | Romp Charles R | EVP, Commercial | S - Sale | $149.85 | -1,323 | 49,973 | -3% | -$198,252 | ||||||
2021-12-20 | SGEN | Himes Vaughn B | Chief Technical Officer | S - Sale | $149.85 | -345 | 180,105 | 0% | -$51,698 | ||||||
| M | 2021-12-20 | SGEN | Dansey Roger D | Chief Medical Officer | S - Sale | $152.72 | -560 | 88,361 | -1% | -$85,520 | |||||
2021-12-20 | SGEN | Siegall Clay B | Pres, CEO | S - Sale | $149.85 | -1,227 | 667,945 | 0% | -$183,866 | ||||||
2021-12-20 | SGEN | Simpson Todd E | CFO | S - Sale | $149.85 | -345 | 128,458 | 0% | -$51,698 | ||||||
2021-12-20 | SGEN | Liu Jean I | GC | S - Sale | $149.85 | -276 | 70,432 | 0% | -$41,359 | ||||||
| D | 2021-12-07 | SGEN | Siegall Clay B | Pres, CEO | S - Sale+OE | $148.66 | -45,449 | 669,172 | -6% | -$6,756,632 | |||||
| M | 2021-11-30 | SGEN | Baker Bros. Advisors LP | Dir, 10% | S - Sale | $160.54 | -394,895 | 42,994,061 | -1% | -$63,396,391 | |||||
| D | 2021-11-11 | SGEN | Himes Vaughn B | Chief Technical Officer | S - Sale+OE | $178.63 | -6,000 | 180,450 | -3% | -$1,071,774 | |||||
| D | 2021-11-03 | SGEN | Simpson Todd E | CFO | S - Sale+OE | $185.00 | -40,232 | 128,803 | -24% | -$7,442,920 | |||||
| D | 2021-11-01 | SGEN | Liu Jean I | GC, EVP, Leg Afairs | S - Sale+OE | $177.41 | -34,876 | 69,091 | -34% | -$6,187,369 | |||||
| D | 2021-10-29 | SGEN | Simpson Todd E | CFO | S - Sale+OE | $180.00 | -33,564 | 126,647 | -21% | -$6,041,523 | |||||
| D | 2021-09-08 | SGEN | Himes Vaughn B | Chief Technical Officer | S - Sale+OE | $150.00 | -6,000 | 178,093 | -3% | -$900,000 | |||||
2021-08-31 | SGEN | Dansey Roger D | Chief Medical Officer | S - Sale | $167.52 | -4,611 | 85,339 | -5% | -$772,414 | ||||||
2021-08-31 | SGEN | Siegall Clay B | Pres, CEO | S - Sale | $167.52 | -14,351 | 668,458 | -2% | -$2,404,015 | ||||||
2021-08-31 | SGEN | Liu Jean I | GC, EVP, Legal Affairs | S - Sale | $167.52 | -3,648 | 68,931 | -5% | -$611,097 | ||||||
2021-08-31 | SGEN | Simpson Todd E | CFO | S - Sale | $167.52 | -3,987 | 126,446 | -3% | -$667,884 | ||||||
2021-08-31 | SGEN | Himes Vaughn B | Chief Technical Officer | S - Sale | $167.52 | -3,584 | 178,093 | -2% | -$600,376 | ||||||
2021-08-31 | SGEN | Romp Charles R | EVP, Commercial | S - Sale | $167.52 | -1,133 | 51,184 | -2% | -$189,795 | ||||||
| M | 2021-08-27 | SGEN | Siegall Clay B | Pres, CEO | S - Sale | $167.90 | -60,432 | 682,809 | -8% | -$10,146,781 | |||||
| D | 2021-08-16 | SGEN | Romp Charles R | EVP, Commercial | S - Sale+OE | $154.55 | -777 | 52,317 | -1% | -$120,088 | |||||
| D | 2021-08-16 | SGEN | Siegall Clay B | Pres, CEO | S - Sale+OE | $154.55 | -2,789 | 743,241 | 0% | -$431,051 | |||||
| D | 2021-08-16 | SGEN | Himes Vaughn B | Chief Technical Officer | S - Sale+OE | $154.55 | -658 | 181,677 | 0% | -$101,697 | |||||
| D | 2021-08-16 | SGEN | Dansey Roger D | Chief Medical Officer | S - Sale+OE | $154.55 | -1,657 | 89,950 | -2% | -$256,096 | |||||
| D | 2021-08-16 | SGEN | Liu Jean I | GC, EVP, Leg Affairs | S - Sale+OE | $154.55 | -718 | 72,579 | -1% | -$110,970 | |||||
| D | 2021-08-16 | SGEN | Simpson Todd E | CFO | S - Sale+OE | $154.55 | -533 | 130,433 | 0% | -$82,377 | |||||
2021-08-13 | SGEN | Dansey Roger D | Chief Medical Officer | S - Sale | $156.59 | -10,000 | 74,435 | -12% | -$1,565,867 | ||||||
| DM | 2021-08-05 | SGEN | Siegall Clay B | Pres, CEO | S - Sale+OE | $162.41 | -29,353 | 715,209 | -4% | -$4,767,220 | |||||
| DM | 2021-07-01 | SGEN | Siegall Clay B | Pres, CEO | S - Sale+OE | $157.04 | -29,353 | 715,209 | -4% | -$4,609,609 | |||||
2021-07-02 | SGEN | Romp Charles R | EVP, Commercial | S - Sale | $158.41 | -703 | 43,187 | -2% | -$111,362 | ||||||
2021-06-16 | SGEN | Dansey Roger D | Chief Medical Officer | S - Sale | $152.22 | -25,109 | 84,435 | -23% | -$3,822,034 | ||||||
| D | 2021-06-07 | SGEN | Himes Vaughn B | Chief Technical Officer | S - Sale+OE | $150.00 | -1,303 | 173,617 | -1% | -$195,450 | |||||
| D | 2021-06-03 | SGEN | Siegall Clay B | Pres, CEO | S - Sale+OE | $144.51 | -29,353 | 715,209 | -4% | -$4,241,801 | |||||
| D | 2021-06-03 | SGEN | Himes Vaughn B | Chief Technical Officer | S - Sale+OE | $144.91 | -10,697 | 173,617 | -6% | -$1,550,090 | |||||
2021-05-17 | SGEN | Romp Charles R | EVP, Commercial | S - Sale | $145.95 | -334 | 43,890 | -1% | -$48,746 | ||||||
2021-05-11 | SGEN | Liu Jean I | GC, EVP, Leg Affairs | S - Sale | $140.00 | -1,061 | 64,051 | -2% | -$148,540 | ||||||
| D | 2021-05-06 | SGEN | Siegall Clay B | Pres, CEO | S - Sale+OE | $134.97 | -29,353 | 715,209 | -4% | -$3,961,824 | |||||
| DM | 2021-04-08 | SGEN | Siegall Clay B | Pres, CEO | S - Sale+OE | $143.79 | -29,353 | 715,209 | -4% | -$4,220,740 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |